PTBP1 and cancer: The decoy oligonucleotide against PTBP1 was successful in inhibiting the oncogenic properties of the cells, which opens up the possibility of treatment of cancer with these types of decoy oligonucleotides, targeting splicing factors that are upregulated in certain cancer types.